Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Buy
59
DXPE Quote, Financials, Valuation and Earnings
Last price:
$87.01
Seasonality move
:
9.6%
Day range:
$84.68 - $87.14
52-week range:
$43.25 - $107.06
Dividend yield:
0%
P/E ratio:
20.59x
P/S ratio:
0.81x
P/B ratio:
3.23x
Volume:
315.8K
Avg. volume:
198.2K
1-year change:
63.65%
Market cap:
$1.4B
Revenue:
$1.8B
EPS (TTM):
$4.23
Analysts' Opinion
-
Consensus RatingDXP Enterprises has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $95.00, DXP Enterprises has an estimated upside of 9.06% from its current price of $87.11.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $95.00 representing 100% downside risk from its current price of $87.11.
Fair Value
-
According to the consensus of 1 analyst, DXP Enterprises has 9.06% upside to fair value with a price target of $95.00 per share.
DXPE vs. S&P 500
-
Over the past 5 trading days, DXP Enterprises has overperformed the S&P 500 by 1.31% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
DXP Enterprises does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DXP Enterprises has grown year-over-year revenues for 3 quarters straight. In the most recent quarter DXP Enterprises reported revenues of $470.9M.
Earnings Growth
-
DXP Enterprises has grown year-over-year earnings for 2 quarters straight. In the most recent quarter DXP Enterprises reported earnings per share of $1.29.
Enterprise value:
1.8B
EV / Invested capital:
1.76x
Price / LTM sales:
0.81x
EV / EBIT:
12.41x
EV / Revenue:
1.03x
PEG ratio (5yr expected):
2.36x
EV / Free cash flow:
23.94x
Price / Operating cash flow:
18.86x
Enterprise value / EBITDA:
10.13x
Gross Profit (TTM):
$556.3M
Return On Assets:
5.75%
Net Income Margin (TTM):
3.91%
Return On Equity:
17.93%
Return On Invested Capital:
7.51%
Operating Margin:
8.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.7B | $1.8B | $407M | $470.9M | |
| Gross Profit | $422M | $505.3M | $556.3M | $122.8M | $148.5M | |
| Operating Income | $97.8M | $138.7M | $145.4M | $30M | $39.3M | |
| EBITDA | $123.5M | $170.2M | $182.3M | $40.5M | $49M | |
| Diluted EPS | $2.47 | $3.89 | $4.23 | $0.95 | $1.29 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $409.4M | $404.6M | $516.1M | $648.6M | $661.9M | |
| Total Assets | $868.1M | $894.2M | $1B | $1.2B | $1.3B | |
| Current Liabilities | $147.1M | $181.1M | $212.9M | $224.2M | $244M | |
| Total Liabilities | $507M | $547.5M | $671.9M | $796.6M | $926.7M | |
| Total Equity | $361.1M | $346.7M | $365.4M | $380.9M | $422.8M | |
| Total Debt | $320.4M | $318.7M | $413.6M | $526.2M | $628.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5.9M | $106.2M | $102.2M | $42.4M | $32.1M | |
| Cash From Investing | -$53.4M | -$22.6M | -$181.7M | -$6.7M | -$16.6M | |
| Cash From Financing | $44.3M | $43.6M | $56.8M | $110.3M | $99.2M | |
| Free Cash Flow | $978K | $94M | $77.1M | $37.3M | $22.7M | |
DXPE
Sector
Market Cap
$1.4B
$618.1M
Price % of 52-Week High
81.37%
74.1%
Dividend Yield
0%
0%
Shareholder Yield
-1.09%
2.42%
1-Year Price Total Return
63.65%
-6.88%
Beta (5-Year)
1.657
0.889
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
0.13%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$85.58
200-day SMA
Buy
Level
$66.43
Bollinger Bands (100)
Buy
Level
68.35 - 97.41
Chaikin Money Flow
Buy
Level
230.1K
20-day SMA
Buy
Level
$84.94
Relative Strength Index (RSI14)
Sell
Level
49.07
ADX Line
Sell
Level
11.56
Williams %R
Sell
Level
-14.3531
50-day SMA
Sell
Level
$93.81
MACD (12, 26)
Buy
Level
12.35
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Sell
Level
-415.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3149)
Buy
CA Score
(Annual)
Level (-0.2087)
Buy
Beneish M-Score
(Annual)
Level (-2.4637)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.8761)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.
Stock Forecast FAQ
In the current month, DXPE has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DXPE average analyst price target in the past 3 months is $95.00.
-
Where Will DXP Enterprises Stock Be In 1 Year?
According to analysts, the consensus estimate is that DXP Enterprises share price will rise to $95.00 per share over the next 12 months.
-
What Do Analysts Say About DXP Enterprises?
Analysts are divided on their view about DXP Enterprises share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DXP Enterprises is a Sell and believe this share price will drop from its current level to $95.00.
-
What Is DXP Enterprises's Price Target?
The price target for DXP Enterprises over the next 1-year time period is forecast to be $95.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DXPE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DXP Enterprises is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of DXPE?
You can purchase shares of DXP Enterprises via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DXP Enterprises shares.
-
What Is The DXP Enterprises Share Price Today?
DXP Enterprises was last trading at $87.01 per share. This represents the most recent stock quote for DXP Enterprises. Yesterday, DXP Enterprises closed at $87.11 per share.
-
How To Buy DXP Enterprises Stock Online?
In order to purchase DXP Enterprises stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
